Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development
Go back to Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development| AGENUS (NASDAQ: AGEN) | Delayed: 3.30 -0.09 (2.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.39 | 52 Week High | $7.49 | |||
| Open | $3.40 | 52 Week Low | $2.61 | |||
| Day High | $3.45 | P/E | N/A | |||
| Day Low | $3.29 | EPS | $-1.10 | |||
| Volume | 505,323 | |||||
| (NASDAQ: INKT) | Delayed: 12.02 -0.32 (2.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.34 | 52 Week High | $ | |||
| Open | $12.55 | 52 Week Low | $ | |||
| Day High | $12.68 | P/E | N/A | |||
| Day Low | $11.80 | EPS | $ | |||
| Volume | 28,191 | |||||

